|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
|
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Gross profit | ||
| Operating expenses: | ||
| Research and development | ||
| Selling, general and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other expense (income): | ||
| Interest expense | ||
| Interest income | ||
| Other expense (income) | ||
| Net loss before provision for income taxes | ||
| Provision for income taxes | ||
| Net loss | ||
| Unrealized loss on marketable securities | ||
| Comprehensive loss | ||
| Less: Undeclared preferred stock dividends | ||
| Net loss attributable to common shareholders, basic | ||
| Net loss attributable to common shareholders, diluted | ||
| Net loss per share attributable to common shareholders, basic | ||
| Net loss per share attributable to common shareholders, diluted | ||
| Weighted average shares of common share outstanding, basic | ||
| Weighted average shares of common share outstanding, diluted |
Loading...
